Skye Bioscience Inc.(SKYE) - 2024 Q3 - Quarterly Results

Bioscience Skye Bioscience Reports Third Quarter 2024 Financial Results and Recent Highlights SAN DIEGO, CA, November 7, 2024 -- Skye Bioscience, Inc. (NASDAQ: SKYE) ("Skye" or the "Company"), a clinical-stage biopharmaceutical company focused on unlocking new therapeutic pathways for metabolic health, today reported financial results for the third quarter ended September 30, 2024, and highlighted recent corporate achievements. "The third quarter marked an important transition for Skye as a metabolic-focuse ...